| scholarly article | Q13442814 |
| P2093 | author name string | Kai Wang | |
| Bin Zheng | |||
| Li Zeng | |||
| Fangfang Liu | |||
| Li Geng | |||
| Qiaojia Huang | |||
| Xiaojuan Ouyang | |||
| P2860 | cites work | PinX1 suppresses bladder urothelial carcinoma cell proliferation via the inhibition of telomerase activity and p16/cyclin D1 pathway | Q21245756 |
| Mammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type M2 is critical for aerobic glycolysis and tumor growth | Q24603549 | ||
| In 2014, can we do better than CA125 in the early detection of ovarian cancer? | Q26825152 | ||
| Pyruvate kinase M2 is a phosphotyrosine-binding protein | Q27650067 | ||
| Marker for renal cell carcinoma (RCC): the dimeric form of pyruvate kinase type M2 (Tu M2-PK) | Q28143504 | ||
| The significance of TU M2-PK tumor marker for lung cancer diagnostics | Q28249860 | ||
| Pyruvate kinase M2-specific siRNA induces apoptosis and tumor regression | Q34136997 | ||
| Evidence for an alternative glycolytic pathway in rapidly proliferating cells | Q34535762 | ||
| Akt2 kinase suppresses glyceraldehyde-3-phosphate dehydrogenase (GAPDH)-mediated apoptosis in ovarian cancer cells via phosphorylating GAPDH at threonine 237 and decreasing its nuclear translocation | Q35604944 | ||
| Nuclear PKM2 regulates β-catenin transactivation upon EGFR activation | Q35607137 | ||
| Extracellular PKM2 induces cancer proliferation by activating the EGFR signaling pathway | Q36853866 | ||
| SIRT2-Mediated Deacetylation and Tetramerization of Pyruvate Kinase Directs Glycolysis and Tumor Growth | Q37059824 | ||
| PKM2 dephosphorylation by Cdc25A promotes the Warburg effect and tumorigenesis | Q37157031 | ||
| AKT-induced PKM2 phosphorylation signals for IGF-1-stimulated cancer cell growth | Q37565415 | ||
| Multiple roles of the cell cycle inhibitor p21(CDKN1A) in the DNA damage response. | Q37680260 | ||
| PKM2 contributes to cancer metabolism | Q38186334 | ||
| Improving Prospects for Targeting RAS. | Q38586951 | ||
| Identification of a cyclin D1 network in prostate cancer that antagonizes epithelial-mesenchymal restraint | Q39053619 | ||
| Overexpression of AKT2/protein kinase Bbeta leads to up-regulation of beta1 integrins, increased invasion, and metastasis of human breast and ovarian cancer cells | Q39124362 | ||
| Pyruvate kinase type M2 is upregulated in colorectal cancer and promotes proliferation and migration of colon cancer cells | Q39312837 | ||
| Pyruvate kinase M2 promotes the growth of gastric cancer cells via regulation of Bcl-xL expression at transcriptional level | Q39342712 | ||
| Reduced p21(WAF1/CIP1) via alteration of p53-DDX3 pathway is associated with poor relapse-free survival in early-stage human papillomavirus-associated lung cancer | Q39591325 | ||
| HER-2/neu overexpression is an independent prognostic factor for intestinal-type and early-stage gastric cancer patients. | Q54551877 | ||
| Quantification of tumor type M2 pyruvate kinase (Tu M2-PK) in human carcinomas | Q73786026 | ||
| P921 | main subject | ovarian cancer | Q172341 |
| cell growth | Q189159 | ||
| overexpression | Q61643320 | ||
| P1104 | number of pages | 10 | |
| P304 | page(s) | 3103-3112 | |
| P577 | publication date | 2018-05-12 | |
| P1433 | published in | Medical Science Monitor | Q15756323 |
| P1476 | title | Overexpression of Pyruvate Kinase Type M2 (PKM2) Promotes Ovarian Cancer Cell Growth and Survival Via Regulation of Cell Cycle Progression Related with Upregulated CCND1 and Downregulated CDKN1A Expression. | |
| P478 | volume | 24 |
| Q64055362 | A Comparative Study of Biological Characteristics and Transcriptome Profiles of Mesenchymal Stem Cells from Different Canine Tissues |
| Q92340166 | Cancer-associated fibroblast-derived exosomal microRNA-98-5p promotes cisplatin resistance in ovarian cancer by targeting CDKN1A |
| Q89942278 | Experimental Study of Hepatocellular Carcinoma Treatment by Shikonin Through Regulating PKM2 |
| Q91584484 | The role of pyruvate kinase M2 in anticancer therapeutic treatments |
Search more.